PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer

被引：0
|
作者：
Kim, H. [1 ]
Kim, J. [2 ]
Byeon, S. [2 ]
Hong, J. Y. [2 ]
Lee, J. [2 ]
Park, S. H. [2 ]
Park, J. O. [2 ]
Park, Y. S. [2 ]
Lim, H. Y. [2 ]
Kang, W. K. [2 ]
Kim, S. T. [2 ]
机构：
[1] Keimyung Univ, Div Hematol Oncol, Dept Internal Med, Dongsan Med Ctr DSMC,Sch Med, Daegu, South Korea
[2] Sungkyunkwan Univ, Div Hematol Oncol, Dept Internal Med, Samsung Med Ctr,Sch Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
69P
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer.
    Kim, Hyera
    Hong, Jung Yong
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer
    Kim, Hongsik
    Kim, Ryul
    Jo, Hyunji
    Kim, Hye Ryeon
    Hong, Joohyun
    Ha, Sang Yun
    Park, Joon Oh
    Kim, Seung Tae
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [3] High PD-L1 expression is associated with treatment response to pembrolizumab in patients with advanced biliary tract cancer
    Kim, G.
    Ahn, S.
    Hwang, J-H.
    Lee, J-C.
    Kim, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer
    Kim, Hyera
    Kim, Jinchul
    Byeon, Seonggyu
    Jang, Kee-Taek
    Hong, Jung Yong
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    ONCOLOGY, 2021, 99 (06) : 365 - 372
  • [5] Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
    Soomin Ahn
    Jong- chan Lee
    Dong Woo Shin
    Jaihwan Kim
    Jin‑ Hyeok Hwang
    Scientific Reports, 10
  • [6] Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers
    Mody, Kabir
    Starr, Jason
    Saul, Michelle
    Poorman, Kelsey
    Weinberg, Benjamin A.
    Salem, Mohamed E.
    VanderWalde, Ari
    Shields, Anthony F.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (06) : 1099 - +
  • [7] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S633 - S638
  • [8] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S633 - S638
  • [9] THE INVESTIGATION OF PD-L1 EXPRESSION AS A PROGNOSTIC MARKER FOR UTERINE SARCOMA
    Sukhin, V. S.
    Danyliuk, S. V.
    Sukhina, O. N.
    Zadnepryanniy, A. Z.
    Lindquist, D.
    Hermelin, H.
    Tarjan, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 568 - 568
  • [10] PD-L1 Expression Is a Favorable Prognostic Marker in Gastric Carcinoma
    Sughayer, Maher A.
    Dabbagh, Tamara Z.
    Battah, Abdelkader H.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (10) : 748 - 754
12345